Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App-Based monitoring shows promise for IBD patients

NCT ID NCT06031038

Disease control Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a web-based telemonitoring system called TECCU for people with moderate-to-severe inflammatory bowel disease (Crohn's disease or ulcerative colitis). 290 participants in Spain were randomly assigned to use the app or receive usual care. The goal was to see if the app helped them stay in remission longer over 52 weeks. Researchers also looked at whether it saved money.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
TECCU web-based telemonitoring software
What this could lead to
If successful, this could show that remote monitoring helps people with complex IBD stay in remission longer and reduces healthcare costs.
What could go wrong
This is a completed study, but telemonitoring may not work for everyone, and results from Spain may not apply to other countries or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

290 people

The number who actually took part.

Started

Sep 2020

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients ≥18a * IBD (CD or UC) diagnosed according to ECCO criteria * Start treatment with immunosuppressants and/or biological therapies due to luminal activity * signed informed consent Exclusion Criteria: * Pregnant women * Presence of active perianal disease, ileoanal reservoir, or definitive stoma * Patients with mental illness or other poorly controlled illness * Patients with active cancer diagnosis * Terminal patients and/or palliative care (SECPAL) * Family members of the research team * Patients without a telephone line to connect with a mobile, tablet and/or computer / Inability to drive * Cognitive or linguistic difficulties * Patients included in another experimental study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Crohn's disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Crohn's disease Inflammatory bowel disease Telemedicine Ulcerative colitis

Contacts and locations

Locations

  • Consorci Sanitari de Terrassa

    Terrassa, Spain

  • Hospital Clínico Universitario Lozano Blesa

    Zaragoza, Spain

  • Hospital Clínico Universitario Valencia

    Valencia, Spain

  • Hospital General Universitario de Elche

    Elche, Spain

  • Hospital Germans Trias i Pujol

    Badalona, Spain

  • Hospital Gregorio Marañón

    Madrid, Spain

  • Hospital Infanta Sofía

    San Sebastián de los Reyes, Spain

  • Hospital La Paz

    Madrid, Spain

  • Hospital La Princesa

    Madrid, Spain

  • Hospital Marqués de Valdecilla

    Santander, Spain

  • Hospital Morales Meseguer

    Murcia, Spain

  • Hospital Nuestra Señora de la Candelaria

    Santa Cruz de Tenerife, Spain

  • Hospital Parc Taulí de Sabadell

    Sabadell, Spain

  • Hospital Puerta del Hierro

    Madrid, Spain

  • Hospital Ramon y Cajal

    Madrid, Spain

  • Hospital Trueta de Girona

    Girona, Spain

  • Hospital Universitario Miquel Servet

    Zaragoza, Spain

  • Hospital Universitario Mutua Terrassa

    Terrassa, Spain

  • Hospital Universitario Reina Sofía

    Córdoba, Spain

  • Hospital Universitario San Cecilio

    Granada, Spain

  • Hospital Universitario de Alicante

    Alicante, Spain

  • Hospital Universitario de Burgos

    Burgos, Spain

  • Hospital Universitario de Cabueñes

    Cabueñes, Spain

  • Hospital Universitario de Fuenlabrada

    Fuenlabrada, Spain

  • Hospital Universitario de Santiago

    Santiago de Compostela, Spain

  • Hospital Universitario y Politécnico la Fe

    Valencia, Valencia, 46026, Spain

  • Hospital de Cruces

    Cruces, Spain

  • Hospital de Huelva

    Huelva, Spain

  • Hospital de Manresa

    Manresa, Spain

  • Hospital de Vigo

    Vigo, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.